With increasing popularity of marijuana, consumers are likely turning to the internet for information regarding medical marijuana. Accuracy of medical marijuana claims is a significant concern because consumers change their medication management based on information from a single website.
Objective
The purpose of this study was to evaluate the accuracy and quality of medical marijuana claims on popular websites. Methods: Commonly used websites containing claims regarding medical marijuana were selected by utilizing three online marketing tools that rank websites based on number of views, number of visitors, and visitor engagement. Once the top ten most popular websites were selected, medical claims regarding marijuana were reviewed for accuracy and quality using evidence-based tools.
Results
Seventy-six percent of claims made by websites were inaccurate and were based on low-quality evidence. Of the medical marijuana claims reviewed, 10% of websites made appropriate cause and effect conclusions. Furthermore, approximately 3% of the medical marijuana claims were written by a healthcare professional.
Conclusion
The findings show there is misleading and inaccurate information readily available to consumers online.
BabsonKASottileJMorabitoD. Cannabis, Cannabinoids, and Sleep: A review of the literature. Curr Psychiatry Rep. 2017;19(4):23.
2.
MuckeMPhillipsTRadbruchL, et al.Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3:CD012182. DOI: 10.1002/14651858.CD012182.pub2
3.
NugentSMMorascoBJO’NeilME, et al.The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Ann Intern Med. 2017;167(5):319–331.
4.
O’NeilMENugentSMMorascoBJ, et al.Benefits and harms of plant-based cannabis for posttraumatic stress disorder: A systematic review. Ann Intern Med. 2017;167(5):332–340.
5.
BogdanovicVMrdjanovicJBorisevI. A Review of the Therapeutic Antitumor Potential of Cannabinoids. J Altern Complement Med. 2017;23(11):831–836.
6.
GoyalHSinglaUGuptaU, et al.Role of cannabis in digestive disorders. Eur J Gasroenterol Hepatol. 2017;29(2):135–143.
Kaiser Family Foundation. The digital divide and access to health information online. Menlo Park, CA. 2011; Report No. 8176.
9.
WartellaERideoutVZupancicH, et al.Teens, health, and technology: a national survey. Center on Media and Human Development. Evanston, IL: Northwestern University; 2015.
10.
BoyerEWShannonMHibberdPL. The internet and psychoactive substance use among innovative drug users. Pediatrics. 2005;115(2):302–305.
BryantPJPaceHA. The Pharmacist’s Guide to Evidence Based Medicine for Clinical Decision Making. 1st ed. Bethesda, MD: American Society of Health-System Pharmacists; 2009.
Marijuana News and Information - The Weed Blog [Internet]. The Intellectualist. The Intellectualist. Accessed June 15, 2018. https://www.themaven.net/theweedblog/
24.
Marijuana news and resources [Internet]. The Cannabist. The Cannabist. Accessed June 15, 2018. https://www.thecannabist.co/
25.
Medical Marijuana Inc. - Legal Cannabis Leader: Hemp CBD Oil [Internet]. Medical Marijuana, Inc. Medical Marijuana, Inc. Accessed June 15, 2018. https://www.medicalmarijuanainc.com/
26.
NORML - Working to Reform Marijuana Laws [Internet]. The National Organization for the Reform of Marijuana Laws. Accessed June 15, 2018. Available from: http://norml.org/
De JongBCPrentissDMcFarlandW, et al.Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38(1):43–46.
29.
PacherPBatkaiSKunosG. Cardiovascular pharmacology of cannabis. Handb Exp Pharmacol. 2005;(168):599–625.
30.
RhyneDNAndersonSLGeddeM, et al.Effects of marijuana on migraine headache frequency in an adult population. Pharmacotherapy. 2016;36(5)505–510.
31.
KeenLAbbateABlandenG, et al.Confirmed marijuana use and lymphocyte count in black people living with HIV. Drug Alcohol Depend. 2017;180:22–25.
32.
PennerEABuettnerHMittlemanMA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583–589.
33.
JadoonKTanGDO’SullivanSE. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2017;2(11):e93760.
34.
FilbeyFMAslanSLuH, et al.Residual effects of THC vs novel measures of brain perfusion and metabolism in a large group of chronic cannabis users. Neuropsychopharmacology. 2017:1–8.
35.
CooperREWilliamsESeegobinS, et al.Cannabinoids in attention-deficit/hyperactive disorder: A randomized-controlled trial. Eur Neuropsychopharmacol. 2017;27:795–808.
36.
DevinskyOCrossJHLauxL, et al.Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21)2011–2020.
37.
SullivanSESunYBennettAJ, et al.Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol. 2009;612(1-3):61–68.
38.
EubanksLMRogersCJBeuscherAE, et al.A molecular link between the active component of marijuana and Alzheimer’s disease pathology. Mol Pharm. 2006;3(6):773–777.
39.
IshadaJHAeurRVittinghoffE, et al.Marijuana use and estimated glomerular filtration rate in young adults. Clin J Am Soc Nephrol. 2017;12(10):1578–1587.
40.
ScottKADalgleishAGLiuWM. The combination of cannabidiol and delta-9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol Cancer Ther. 2014;13(12)2955–2967.
41.
BachhuberMASolonerBCunninhamCO, et al.Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10)1668–1673.
42.
AntonelliTTomasiniMCTattoliM, et al.Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex. 2005;15(12):2013–2020.
43.
VenderovaKRuzickaEVorisekV, et al.Survey on cannabis use in Parkinson’s disease: Subjective improvement of motor symptoms. Mov Disord. 2004;19(9)1102–1106.
44.
ScottKADalgleishAGLiuWM. Anticancer effects of phytocannabinoids used with chemotherapy leukaemia cells can be improved by altering the sequence of their administration. Int J Oncol. 2017;51(1):369–377.
45.
BrunetLMoodieEEMRolletK; et al.Canadian Co-infection Cohort Investigators. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: A longitudinal cohort analysis. Clin Infect Dis. 2015;57(5):663–670.
46.
HayakawaKMishimaKFujiwaraM. Therapeutic potential of non-psychotropic cannabidiol in ischemic stroke. Pharmaceuticals. 2010;3(7):2197–2212.
47.
ReimanAWeltyMSolomonP. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2(1)160–166.
48.
RhyneDNAndersonSLGeddeM, et al.Effects of medical marijuana on migraine headache frequency in an adult population. Pharmacotherapy. 2016;36(5):505–510.
49.
LivingstonMDBarnettTEDelcherC, et al.Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. Am J Public Health. 2017;107(11)1827–1829.
50.
BlancoCHasinDSWallMM, et al.Cannabis use and risk of psychiatric disorders: Prospective evidence from a US national longitudinal study. JAMA Psychiatry. 2016;73(4)388–395.
51.
GoyalHGuerresoKSmithB, et al.Severity and outcomes of acute alcoholic pancreatitis in cannabis users. Transl Gastroenterol Hepatol. 2017;2(60):1–8.
52.
SingerMAzimAO’KeefeT, et al.How does marijuana affect outcomes after trauma in ICU patients? A propensity-matched analysis. J Trauma Acute Care Surg. 2017;83(5):846–849.
53.
KindredJHLiKKetelhutNB, et al.Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation. Complement Ther Med. 2017;33:99–104.
54.
IshidaJHAuerRVittinghoffE, et al.Marijuana use and estimated glomerular filtration rate in young adults. Clin J Am Soc Nephrol. 2017;12(10):1578–1587.
55.
AdamsJWBryantKJEdelmanJE, et al.Associated of cannabis, stimulant, and alcohol use with mortality prognosis among HIV-infected men. AIDS Behav. 2018;22(4):1341–1351. DOI 10.1007/s10461-017-1905-4
56.
Cavazos-RehgPAKraussMJCahnE, et al.Marijuana promotion online: an investigation of dispensary practices. Prev Sci. 2019;20(2):280–290.
57.
KraussMJSowlesSJSehiA, et al.Marijuana advertising exposure among current marijuana users in the U.S. Drug Alcohol Depend. 2017;174:192–200.
HarewoodGCHendrickLM. Prospective, controlled assessment of the impact of formal evidence-based medicine teaching workshop on ability to appraise the medical literature. Ir J Med Sci. 2010;179(1):91–94.
61.
BergerBSteckelbergAMeyerG, et al.Training of patient and consumer representatives in the basic competencies of evidence-based medicine: a feasibility study. BMC Med Educ. 2010;10:16.
62.
BergerBGerlachAGrothS, et al.Competence training in evidence-based medicine for patients, patient counsellors, consumer representatives and healthcare professionals in Austria: a feasibility study. A. Z Evid Fortbild Qual Gesundhwes. 2013;107(1):44–52.
